Hexokinase 2 nonmetabolic function‐mediated phosphorylation of IκBα enhances pancreatic ductal adenocarcinoma progression
Cancer Science · 2024
DOI: 10.1111/cas.16204 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Yingying Tong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, Beijing Luhe Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Hexokinase, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, NF-KappaB Inhibitor alpha. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing Municipal Natural Science Foundation, R&D Program of Beijing Municipal Education Commission, National Natural Science Foundation of China.
Abstract (Originalsprache)
Aberrant signaling in tumor cells induces nonmetabolic functions of some metabolic enzymes in many cellular activities. As a key glycolytic enzyme, the nonmetabolic function of hexokinase 2 (HK2) plays a role in tumor immune evasion. However, whether HK2, dependent of its nonmetabolic activity, plays a role in human pancreatic ductal adenocarcinoma (PDAC) tumorigenesis remains unclear. Here, we demonstrated that HK2 acts as a protein kinase and phosphorylates IκBα at T291 in PDAC cells, activating NF‐κB, which enters the nucleus and promotes the expression of downstream targets under hypoxia. HK2 nonmetabolic activity‐promoted activation of NF‐κB promotes the proliferation, migration, and invasion of PDAC cells. These findings provide new insights into the multifaceted roles of HK2 in tumor development and underscore the potential of targeting HK2 protein kinase activity for PDAC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Center, Beijing Luhe Hospital, Capital Medical University, Beijing, China.
- Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
ORCID-Profile: Dong Yan
Förderung
- Beijing Municipal Natural Science Foundation
- R&D Program of Beijing Municipal Education Commission
- National Natural Science Foundation of China
Zitieren
APA
Tong, Y., Liu, X., Wu, L., Xiang, Y., Wang, J., Cheng, Y., Zhang, C., Han, B., Wang, L., & Yan, D. (2024). Hexokinase 2 nonmetabolic function‐mediated phosphorylation of IκBα enhances pancreatic ductal adenocarcinoma progression. Cancer Science. https://doi.org/10.1111/cas.16204
Vancouver
Tong Y, Liu X, Wu L, Xiang Y, Wang J, Cheng Y, et al. Hexokinase 2 nonmetabolic function‐mediated phosphorylation of IκBα enhances pancreatic ductal adenocarcinoma progression. Cancer Science. 2024. doi:10.1111/cas.16204
BibTeX
@article{Tong2024,
author = {Tong, Yingying and Liu, Xin and Wu, Lihui and Xiang, Yaoxian and Wang, Jing and Cheng, Yurong and Zhang, Chan and Han, Baojuan and Wang, Li and Yan, Dong},
title = {Hexokinase 2 nonmetabolic function‐mediated phosphorylation of IκBα enhances pancreatic ductal adenocarcinoma progression},
journal = {Cancer Science},
year = {2024},
doi = {10.1111/cas.16204}
}
EUVIMED